Phase II trial of neoadjuvant nivolumab with cisplatin and gemcitabine in muscle-invasive bladder cancer  patients undergoing radical cystectomy.

Authors

Shilpa Gupta

Shilpa Gupta

University of Minnesota Masonic Cancer Center, Minneapolis, MN

Shilpa Gupta , Neeraj Agarwal , Badrinath R. Konety , Christopher J. Weight , Bharat Thyagarajan , Paari J Murugan , Joseph S Koopmeiners , Guru Sonpavde

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2018 Genitourinary Cancers Symposium

Session Type

Trials in Progress Poster Session

Session Title

Trials in Progress Poster Session B: Prostate Cancer, Urothelial Carcinoma, and Penile, Urethral and Testicular Cancers

Track

Urothelial Carcinoma,Prostate Cancer,Penile, Urethral, and Testicular Cancers

Sub Track

Urothelial Carcinoma

Clinical Trial Registration Number

NCT03294304

Citation

J Clin Oncol 36, 2018 (suppl 6S; abstr TPS528)

DOI

10.1200/JCO.2018.36.6_suppl.TPS528

Abstract #

TPS528

Poster Bd #

N6

Abstract Disclosures